EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy.
EGFRvIII peptide PEPvIII is a synthetic peptide derived from the epidermal growth factor receptor variant III (EGFRvIII), a mutant form of EGFR commonly identified in certain malignant gliomas and other cancers. As a well-characterized neoepitope, PEPvIII represents a unique sequence created by the in-frame deletion of exons 2-7 in the EGFR gene, resulting in a novel glycine at the fusion junction. This biochemical property makes the peptide a valuable tool for investigating tumor-specific antigens, immune recognition, and molecular mechanisms underlying oncogenic signaling. Its distinct sequence and immunological relevance have positioned it as a focal point in cancer biology research, particularly in studies seeking to elucidate the roles of tumor-specific mutations and their downstream effects.
Epitope mapping: PEPvIII serves as an essential substrate for epitope mapping studies aimed at characterizing antibody specificity and T cell receptor recognition. By providing a defined sequence corresponding to the EGFRvIII neoantigen, the peptide enables researchers to assess immune responses at the molecular level, facilitating the identification of binding motifs and critical residues involved in antigen recognition. Such applications are instrumental in dissecting the fine specificity of monoclonal antibodies, evaluating cross-reactivity, and optimizing reagents for detecting EGFRvIII expression in tumor samples.
Immunogenicity assessment: The peptide is widely employed in assays designed to evaluate the immunogenic potential of EGFRvIII in preclinical research settings. In vitro studies utilizing PEPvIII allow for the stimulation of human or murine lymphocytes, enabling the measurement of antigen-specific responses such as cytokine production, proliferation, or cytotoxic activity. These investigations provide insights into the mechanisms by which the immune system recognizes and responds to tumor-specific mutations, supporting the development of immunological models and the refinement of antigen-targeted strategies.
Assay development: PEPvIII is frequently incorporated into the design and validation of immunoassays, including enzyme-linked immunosorbent assays (ELISAs), flow cytometry-based detection systems, and peptide-MHC multimer platforms. Its defined sequence and immunological relevance make it an ideal positive control or standard for quantifying EGFRvIII-specific antibodies or T cells in experimental samples. By enabling sensitive and specific detection, the peptide supports robust assay performance and reproducibility in translational research, biomarker discovery, and quality control workflows.
Peptide-functional studies: The unique biochemical features of PEPvIII facilitate its use in functional studies probing the consequences of EGFRvIII expression and signaling. Researchers utilize the peptide to investigate mechanisms of receptor activation, downstream pathway modulation, and the impact of neoepitope presentation on cellular behavior. Such studies contribute to a deeper understanding of oncogenic signaling networks and the interplay between mutant receptor variants and the tumor microenvironment.
Peptide synthesis and conjugation: PEPvIII is also leveraged as a model substrate in peptide synthesis and conjugation protocols. Its well-defined sequence and immunological significance make it suitable for method development, optimization of solid-phase peptide synthesis strategies, and evaluation of conjugation chemistries for coupling to carrier proteins or nanoparticles. These applications are critical for generating high-quality research reagents and for advancing the production of custom peptides tailored to specific experimental needs.
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. Cationic cell-penetrating peptides are potent furin inhibitors
3. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More